[Results of one-stage endoprosthesis revision in periprosthetic infection cause by methicillin-resistant

J Kordelle1, L Frommelt, D Klüber

  • 1Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Abstract

Insights

One-stage exchange arthroplasty is a viable treatment for periprosthetic joint infections caused by methicillin-resistant Staphylococcus aureus (MRSA). While recurrence rates are higher than in unselected cases, this approach offers a potential solution for challenging MRSA infections.

Area of Science:

  • Orthopedic surgery
  • Infectious disease management
  • Biomaterials in medicine

Context:

  • Periprosthetic joint infections (PJIs) pose significant challenges in orthopedic surgery.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a difficult-to-treat pathogen in PJIs.
  • One-stage exchange arthroplasty is an alternative surgical strategy for PJI management.

Purpose:

  • To evaluate the efficacy of one-stage exchange arthroplasty for treating MRSA periprosthetic joint infections.
  • To compare the outcomes of MRSA PJI treatment with one-stage exchange to general PJI treatment outcomes.
  • To assess the success rate and recurrence patterns of this specific treatment approach.

Summary:

  • Twenty patients with MRSA PJI underwent one-stage exchange arthroplasty (15 hip, 5 knee).
  • The overall success rate was 61% after a single procedure, with a mean follow-up of 16 months.
  • Postoperative joint aspirations showed high correlation with clinical outcomes, aiding in infection assessment.

Impact:

  • One-stage exchange arthroplasty demonstrates potential for MRSA PJI treatment, though with a notable recurrence rate.
  • The study suggests specific antibiotic combinations (vancomycin/ofloxacin) for polymethylmethacrylate cement.
  • Further research and procedural refinement are recommended for optimizing outcomes in challenging MRSA PJI cases.